← SynDRA
DELANZOMIB
SynDRA canonical compound SYN0009275 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | CMA1 | CTSG | CYP3A4 | ELANE |
|---|
| Mechanism of action | proteasome inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PSMB9
- PSMB8
- PSMB5
- PSMB2
- PSMB10
- PSMB1
- ADAM17
- MMP2
- F7
- KLKB1
- MME
- MMP1
- MMP12
- MMP8
- MMP3
- MMP7
- F10
- PLAT
- PLG
- F2
- ECE1
- CAPN1
- DPP4
- CASP1
- CASP2
- CASP3
- CASP7
- CASP8
- CASP9
- CTSB
- CTSD
- CTSE
- CTSH
- CTSL
- CTSS
- CTSZ
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ABCB5
- ADCY9
- ATXN2
- HLAB
- IFNB1
- IFNG
- KSYK
- MDR1
- MITF
- NSD2
- PARP1
- SNCA
- SYK
- SYUA
- TFE3
- TP53
Drug classes
Cross-references
Synonyms
- CEP-18770
- CIP-18770
- CT-47098
- NPH-007098
- NPH007098
- ((R)-1-((2S,3R)-3-hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutan-2-yl)boronic acid
- s1157
- ZINC202536926
- SB16695
- SW219161-1
- boronic acid, b-[(1r)-1-[[(2s,3r)-3-hydroxy-1-oxo-2-[[(6-phenyl-2-pyridinyl)carbonyl]amino]butyl]amino]-3-methylbutyl]-
- CEP 18770
- Delanzomib (CEP-18770)
- ((R)-1-((2S,3R)-3-Hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutyl)boronic acid
- CT 47098
- Delanzomib [USAN]
- CHEMBL270515
- 6IF28942WO
- Delanzomib (USAN)
- [(1R)-1-[(2S,3R)-3-hydroxy-2-[(6-phenylpyridin-2-yl)formamido]butanamido]-3-methylbutyl]boronic acid
- CEP18770
- ((1R)-1-(((2s,3r)-3-hydroxy-2-(((6-phenylpyridin-2-yl)carbonyl)amino)-1-oxobutyl)amino)-3-methylbutyl)boronic acid
- [(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid
- [(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid.
- Boronic acid, ((1R)-1-(((2S,3R)-3-hydroxy-1-oxo-2-(((6-phenyl-2-pyridinyl)carbonyl)amino)butyl)amino)-3-methylbutyl)-
- Delanzomib [USAN:INN]
- delanzomibum
- UNII-6IF28942WO
- [(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid
- Delanzomib, free base
- DELANZOMIB [INN]
- CEP-18770; Delanzomib
- DELANZOMIB [WHO-DD]
- SCHEMBL555047
- CHEBI:141530
- DTXSID901025656
- AMY21646
- EX-A2040
Look up DELANZOMIB in the interactive SynDRA portal →